Experts believe the epidemic is mainly contained within Equatorial Guinea, though new cases have emerged approximately 150 kilometers away, close to the borders of Cameroon and Gabon. This suggests that the virus is spreading further, prompting calls for intensified response efforts.
Matshidiso Moeti, the WHO's Regional Director for Africa, highlights the need to "swiftly halt the transmission chain and avert a potential large-scale outbreak and loss of human lives." According to Moeti, implementing a wide range of epidemic response measures can effectively control and stop the highly virulent Marburg virus.
The zoonotic virus originates from the Egyptian fruit bat, Rousettus aegyptiacus, a species widespread in Africa, the Middle East, the Mediterranean, and the Indian subcontinent. Being in close contact with these animals increases the risk of Marburg virus infection.
Symptoms of the Marburg virus include high fever, headache, muscle aches, and chills, with an incubation period ranging from 2 to 21 days. Additional symptoms such as diarrhea, vomiting, abdominal pain, and rash may appear within a few days. Severe symptoms encompass liver failure, multiorgan dysfunction, and extensive hemorrhaging.
Unfortunately, there are currently no vaccines or treatments available for the Marburg virus. However, some potential treatments are under development and have recently advanced beyond Phase 1 trials. Intravenous fluid therapy and symptom management can improve survival rates, but the Marburg virus still causes a mortality rate of up to 88%.
Efficient monitoring and response efforts are crucial to control the spread of the Marburg virus outbreak and minimize its impact on public health. As experts continue to investigate and understand the virus, it is essential to remain vigilant and take necessary precautions.
Post a Comment